Anne Marie Kaulfers
Pediatric Endocrinology · Mobile, ALNPI 1639386733
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (50.1%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 22.1%. Among pediatric endocrinology clinicians in AL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 365 payments — averaging $51.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$4K
- Arbor Pharmaceuticals, Inc.$3K
- AbbVie$3K
- Novo Nordisk$1K
- Dexcom, Inc.$816
- Insulet Corporation$781
- plus $5K from 29 others
What the payments were for
- Consulting fees$3,20017%
- Speaking & faculty fees$3,69020%
- Travel & lodging$2,17712%
- Food & beverage$9,39650%
- Education$2922%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 18 | $4,147 |
| Arbor Pharmaceuticals, Inc. | 12 | $3,481 |
| AbbVie | 49 | $3,468 |
| Novo Nordisk | 45 | $1,007 |
| Dexcom, Inc. | 26 | $816 |
| Insulet Corporation | 23 | $781 |
| Sanofi-aventis U.S. LLC | 21 | $630 |
| Medtronic(2 entities) | 14 | $567 |
| Xeris Pharmaceuticals, Inc. | 22 | $410 |
| Ascendis Pharma Endocrinology Inc | 12 | $335 |
| BETA Bionics, Inc. | 10 | $306 |
| Tandem Diabetes Care, Inc. | 12 | $286 |
| Lilly USA, LLC | 12 | $260 |
| Tolmar, Inc. | 15 | $253 |
| BD | 7 | $239 |
| Pfizer | 13 | $217 |
| AstraZeneca | 3 | $183 |
| Azurity Pharmaceuticals, Inc. | 8 | $169 |
| Biogen | 1 | $123 |
| Sanofi | 1 | $122 |
| Sequel Med Tech, LLC | 3 | $118 |
| Rochester Medical Corporation | 2 | $117 |
| Ultragenyx Pharmaceutical Inc. | 5 | $103 |
| Biomarin Pharmaceutical Inc. | 4 | $102 |
| Kyowa Kirin, Inc. | 4 | $95 |
| Tolmar Pharmaceuticals, Inc. | 5 | $84 |
| Rhythm Pharmaceuticals, Inc. | 4 | $82 |
| Endo USA, Inc. | 3 | $61 |
| Alnylam Pharmaceuticals Inc. | 3 | $56 |
| Endo Pharmaceuticals Inc. | 2 | $35 |
| Sandoz | 2 | $31 |
| Eton Pharmaceuticals, Inc. | 1 | $21 |
| Amryt Pharma Holdings Ltd | 1 | $17 |
| GSK | 1 | $16 |
| Ferring Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CRENESSITY$3,678
- Triptodur$3,356
- Lupron Depot$2,597
- MINIMED 780G$270
- TZIELD$224
- Omnipod$152
- SKYTROFA$124
- SPINRAZA$123
- Minimed 670G System$100
How this compares
$18,755 in reported general payments places this provider in the 90th percentile of 22 pediatric endocrinology providers in Alabama.
Other pediatric endocrinology in Mobile
- Whei Ying LimMobile$5K
- Eliana Perez GarciaMobile$5K
- Kenneth RettigMobile$2K
- Samar BhowmickMobile$944
- Ambika AshrafBirmingham$39K
- Chelsea ZimmermanOpelika$29K
- Mary ScottBirmingham$9K
- Heather ChoatDothan$3K
- Kenneth McCormickBirmingham$2K
- Christy FosterBirmingham$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.